Our FWF Emerging Fields Consortium brings together six complementary research groups (Falk, Grebien, Hein, Karagöz, Seruggia, Tomazou) across leading biomedical research institutions in Vienna to investigate the ribosome and translational control as a new and largely unexplored layer of pediatric cancer biology and therapy resistance.
Find more information here: Emerging Fields - FWF
By combining cutting-edge genomic, proteomic, biochemical and structural approaches, we aim to decode cancer-specific mechanisms of translational regulation, the “ribosome code”, and iden-tify novel therapeutic vulnerabilities that could lead to safer and more effective treatments for children and adolescents with solid and hematological cancers.
As a postdoctoral researcher, you will join one of the participating research groups while being part of a multidisciplinary consortium bringing together complementary expertise in pediatric cancer, translational regulation, RNA biology, functional genomics, proteomics and structural biology.
Successful candidates should have
Applications should contain a one-page research statement outlining your scientific interests, how they connect to the aims of the Emerging Fields Consortium, and the research questions you would be particularly interested in pursuing. Furthermore, it should include the following documents:
The application deadline is 15.11.2026. Applications are collected centrally on behalf of the participating research groups to provide candidates with one straightforward application process.
Please apply by following the link below:
https://ccri.at/working-at-the-ccri/job-openings/?jh=wjkuuywpmo42zcvn9iwpuo576pbxhxd